摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N'-bis<(tert-butyloxycarbonyl)glycyl>cystamine | 97314-11-9

中文名称
——
中文别名
——
英文名称
N,N'-bis<(tert-butyloxycarbonyl)glycyl>cystamine
英文别名
[Boc-Gly-CSA]2;Boc-Gly-CSA;[Boc-Gly-cysteamine]2;tert-butyl N-[2-[2-[2-[[2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]ethyldisulfanyl]ethylamino]-2-oxoethyl]carbamate
N,N'-bis<(tert-butyloxycarbonyl)glycyl>cystamine化学式
CAS
97314-11-9
化学式
C18H34N4O6S2
mdl
——
分子量
466.623
InChiKey
OMUBLDOVSMDJNE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    98-100 °C
  • 沸点:
    710.9±60.0 °C(Predicted)
  • 密度:
    1.195±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    30
  • 可旋转键数:
    15
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.78
  • 拓扑面积:
    186
  • 氢给体数:
    4
  • 氢受体数:
    8

SDS

SDS:92ca9f9cd5d0d5b8baf8755555edd4ff
查看

反应信息

  • 作为反应物:
    描述:
    N,N'-bis<(tert-butyloxycarbonyl)glycyl>cystamine三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 生成 Gly-CSA
    参考文献:
    名称:
    Chemical functionalization and modification of surface-bound cystamine–glycine monolayers on gold nanoparticles
    摘要:
    在此,我们报告了用甘氨酸-胱胺(Gly-CSA)稳定基团进行表面修饰的金纳米粒子的合成、表征和后功能化。我们的研究表明,金单层保护团簇(MPCs)可通过布氏-施氏法(Brust-Schiffrin method)使用 Boc-Gly-CSA 稳定剂合成,然后用三氟乙酸有效去除 Boc 保护基团。我们通过紫外-可见光、TEM 和 1H NMR 对得到的 Gly-CSA Au MPC 进行了表征,它们在溶液中长期保持稳定。最后,我们展示了使用硬脂酸活化酯和 Bodipy 染料衍生物可对 Gly-CSA Au MPCs 进行进一步功能化,其产量几乎达到了等比级数。因此,这项工作为改变 MPCs 的表面化学性质提供了另一种通用方法。
    DOI:
    10.1139/v08-025
  • 作为产物:
    参考文献:
    名称:
    Combinatorial Synthesis through Disulfide Exchange: Discovery of Potent Psammaplin A Type Antibacterial Agents Active against Methicillin-ResistantStaphylococcus aureus (MRSA)
    摘要:
    Psammaplin A is a symmetrical bromotyrosine -derived disulfide natural product isolated from the Psammaplysilla sponge, which exhibits in vitro antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). Inspired by the structure of this marine natural product, a combinatorial scrambling strategy for the construction of heterodimeric disulfide analogues was developed and applied to the construction of a 3828-membered library starting from 88 homodimeric disulfides. These psammaplin A analogues were screened directly against various gram positive bacterial strains leading to the discovery of a series of potent antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA), Among the most active leads derived from these studies are compounds 104. 105, 113, 115, 123, and 128. The present, catalytically-induced. disulfide exchange strategy may be extendable to other types of building blocks bearing thiol groups facilitating the construction of diverse discovery-oriented combinatorial libraries.
    DOI:
    10.1002/1521-3765(20011001)7:19<4280::aid-chem4280>3.0.co;2-3
点击查看最新优质反应信息

文献信息

  • Ferrocenoyl glycylcystamine: organization into a supramolecular helicate structure
    作者:Irene Bediako-Amoa、Roberta Silerova、Heinz-Bernhard Kraatz
    DOI:10.1039/b206647e
    日期:2002.10.11
    Extensive intermolecular hydrogen bonding in ferrocenoyl glycylcystamine gives rise to a novel ordered double helical arrangement with a helical pitch height of 14 Å.
    二茂铁酰基甘氨酰胱胺中广泛的分子间氢键产生了一种新颖的有序双螺旋排列,螺距高度为 14 Å。
  • Synthesis, structure and electrochemistry of ferrocene–peptide macrocycles
    作者:Somenath Chowdhury、Gabriele Schatte、Heinz-Bernhard Kraatz
    DOI:10.1039/b401039f
    日期:——
    Redox active cyclopeptides Fc[CSA]2 (5), Fc[Gly–CSA]2 (6), Fc[Ala–CSA]2 (7), Fc[Val–CSA]2 (8) and Fc[Leu–CSA]2 (9) (CSA = cysteamine) which are formed by the reaction of ferrocenedicarboxylic acid with peptide cystamines at high dilutions. These systems exhibit H-bonding involving the amide NH in solution as shown by their temperature dependent NMR spectra. With the exception of 5, the ferrocene macrocycles display intramolecular N⋯O cross-ring H-bonding in the solid state involving the amino acids proximal to the ferrocene.
    氧化还原活性环肽 Fc[CSA]2 (5)、Fc[GlyâCSA]2 (6)、Fc[AlaâCSA]2 (7)、Fc[ValâCSA]2 (8) 和 Fc[LeuâCSA]2 (9)(CSA = 半胱胺)是二茂铁二羧酸与肽胱胺在高稀释度下反应生成的。这些体系在溶液中表现出涉及酰胺 NH 的 H 键,这一点可以从它们与温度相关的 NMR 光谱中看出。除 5 外,二茂铁大环在固态下显示出分子内 Nâ¯O 跨环 H 键,涉及二茂铁附近的氨基酸。
  • Chemical functionalization and modification of surface-bound cystamine–glycine monolayers on gold nanoparticles
    作者:Mita Dasog、Amir Kavianpour、Matthew F Paige、Heinz-Bernhard Kraatz、Robert W.J. Scott
    DOI:10.1139/v08-025
    日期:2008.5.1

    Herein, we report the synthesis, characterization, and post-functionalization of Au nanoparticles that have been surface-modified with glycine–cystamine (Gly-CSA) stabilizing groups. We show that Au monolayer protected clusters (MPCs) can be synthesized via the Brust–Schiffrin method using a Boc-Gly–CSA stabilizer, followed by efficient removal of the Boc protecting group with trifluoroacetic acid. The resulting Gly–CSA Au MPCs are characterized via UV–vis, TEM, and 1H NMR, and are stable in solution over long periods of time. Finally, we show that the Gly–CSA Au MPCs can be further functionalized with nearly stoichiometric yields using activated esters of stearic acid and a Bodipy dye derivative. Thus, this work provides an alternative, general approach for the modification of the surface chemistry of MPCs.Key words: gold nanoparticles, peptide stabilizers, dyes.

    在此,我们报告了用甘氨酸-胱胺(Gly-CSA)稳定基团进行表面修饰的金纳米粒子的合成、表征和后功能化。我们的研究表明,金单层保护团簇(MPCs)可通过布氏-施氏法(Brust-Schiffrin method)使用 Boc-Gly-CSA 稳定剂合成,然后用三氟乙酸有效去除 Boc 保护基团。我们通过紫外-可见光、TEM 和 1H NMR 对得到的 Gly-CSA Au MPC 进行了表征,它们在溶液中长期保持稳定。最后,我们展示了使用硬脂酸活化酯和 Bodipy 染料衍生物可对 Gly-CSA Au MPCs 进行进一步功能化,其产量几乎达到了等比级数。因此,这项工作为改变 MPCs 的表面化学性质提供了另一种通用方法。
  • Method of coupling polysaccharides to proteins
    申请人:DE STAAT DER NEDERLANDEN VERTEGENWOORDIGD DOOR DE MINISTER VAN WELZIJN, VOLKSGEZONDHEID EN CULTUUR
    公开号:EP0848011A1
    公开(公告)日:1998-06-17
    A novel method of covalently coupling polysaccharides to other biopolymers is provided, using an amino-thiol linker represented by formula 1         H2N-[(CH2)m-CHR1-CR2R3-A]q-CHR4-(CHR5)p-CHR6-S-R7     1 wherein A is a direct bond or a group having the formula         -Z-(CH2)m-CHR1-CHR2R3}nZ-, m is an integer from 0 to 5; n is an integer from 0 to 3; p is an integer from 0 to 2; q is the integer 0 or 1; R1 is hydrogen or C1-C6 alkyl, optionally substituted by amino, hydroxyl, carboxyl, C1-C4 alkoxycarbonyl, carbamoyl, mono- or di-C1-C4-alkylcarbamoyl or N-(α-carboxyalkyl)carbamoyl, or, if m ≠ 0, R1 is hydroxyl, amino or peptidyl-amino; R2 and R3 are independently hydrogen or C1-C4 alkyl, or together form an oxo group; R4 is hydrogen, C1-C4 alkyl, carboxyl, C1-C4 alkoxycarbonyl, carbamoyl, mono- or di-C1-C4-alkylcarbamoyl or N-(α-carboxyalkyl)carbamoyl; R5 is hydrogen, methyl, hydroxy or C1-C7 acyloxy; R6 is hydrogen or methyl; R7 is hydrogen or a thiol-protecting group or a group having the formula         -S-CHR6-(CHR5)p-CHR4-[A-CR2R3-CHR1-(CH2)m]q-NH2; and Z is imino, methylimino, oxygen or sulphur.
    提供了一种将多糖与其他生物聚合物共价偶联的新方法,使用了由式 1 表示的氨基硫醇连接剂 H2N-[(CH2)m-CHR1-CR2R3-A]q-CHR4-(CHR5)p-CHR6-S-R7 1 其中 A 是直接键或具有以下式子的基团 -Z-(CH2)m-CHR1-CHR2R3}nZ-, m 是 0 至 5 的整数; n 是 0 至 3 的整数; p 是 0 至 2 的整数; q 是 0 或 1 的整数; R1 是氢或 C1-C6 烷基,任选被氨基、羟基、羧基、C1-C4 烷氧基羰基、氨基甲酰基、单-或二-C1-C4-烷基氨基甲酰基或 N-(α-羧基烷基)氨基甲酰基取代,或者,如果 m≠0,R1 是羟基、氨基或肽基氨基; R2 和 R3 独立地为氢或 C1-C4 烷基,或共同形成一个氧代基团; R4 是氢、C1-C4-烷基、羧基、C1-C4-烷氧基羰基、氨基甲酰基、单-或双-C1-C4-烷基氨基甲酰基或 N-(α-羧基烷基)氨基甲酰基; R5 是氢、甲基、羟基或 C1-C7 乙酰氧基; R6 是氢或甲基 R7 是氢或硫醇保护基团或具有以下式子的基团 -S-CHR6-(CHR5)p-CHR4-[A-CR2R3-CHR1-(CH2)m]q-NH2; and Z 是亚氨基、甲基亚氨基、氧或硫。
  • Synthesis and radioprotective activity of new cysteamine and cystamine derivatives
    作者:J. Oiry、J. Y. Pue、J. L. Imbach、M. Fatome、H. Sentenac-Roumanou、C. Lion
    DOI:10.1021/jm00161a015
    日期:1986.11
    A variety of N-(aminoalkanoyl)-S-acylcysteamine and N,N'-bis(aminoalkanoyl)cystamine salt derivatives were synthesized. Toxicity and radioprotective activity (as the dose reduction factor DRF) were determined in vivo on mice and compared to WR 2721 and S-acetylcysteamine hydrochloride. One of the most interesting compounds of this series was N-glycyl-S-acetylcysteamine trifluoroacetate (16, I 102). Structure-activity relationships are discussed.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物